NOTE 8 - SOFTWARE LICENSING (Details) - Software Service, Support and Maintenance Arrangement [Member] $ / shares in Units, shares in Millions, $ in Millions	9 Months Ended
	Sep. 30, 2016 USD ($) $ / shares shares
NOTE 8 - SOFTWARE LICENSING (Details) [Line Items]
Deferred Revenue, Description	the Company signed an agreement to grant a perpetual license for the source code of its QHIX platform (the “Licensed Software”) to a major software and services firm (the “Licensee”) who will serve as the Company’s channel partner. The Licensee provides health claims processing systems to over 400 health plans/payors and health care providers across the country covering over 150 million members. This agreement provides exclusivity to the Licensee in certain segments of the market, provided the Licensee meets certain performance requirements. Under this agreement, the Licensee paid the Company an upfront cash payment of $3.1 million, which has been included in revenue during the three months ended September 30, 2016 upon satisfaction of certain conditions, in addition to quarterly royalty payments based on the revenues it generates by deploying the Licensed Software. The royalty payment agreement calls for the Licensee to pay up to $90 million to the Company by sharing revenue generated from the sale of Licensed Software. The license will be considered fully paid if and when the Company receives from the Licensee a total of $90 million in royalties. In addition to the upfront payment and royalty per this agreement, the Company will also receive annual fees for maintenance, support and upgrades; and professional fees for services such as implementation of QHIX and other related services. While the upfront payment is certain, the Company may not receive the full stipulated maximum royalty payments from this agreement.
Deferred Revenue	$ 3.1
Royalty Agreement, Maximum Amount	$ 90.0
Class of Warrant or Rights, Granted (in Shares) | shares	3
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ / shares	$ 0.75
Warrant Term	3 years